Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine.
D000090:Acetoacetates / Q000097:blood; D000328:Adult; D000661:Amphetamine / Q000009:adverse effects*; D001067:Appetite Depressants / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D005990:Glycerol / Q000097:blood; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D007328:Insulin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D011674:Pulse / Q000187:drug effects; D014280:Triglycerides / Q000097:blood
D000090:Acetoacetates; D001067:Appetite Depressants; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007093:Imidazoles; D007211:Indoles; D007328:Insulin; D014280:Triglycerides; D002784:Cholesterol; D000661:Amphetamine; D005990:Glycerol